Genetic Risk Assessment of Periodontal Disease in Healthy Patients
- *Corresponding Author:
- Dorina Lauritano
Department of traslational medicine and surgery
Neuroscience Centre of Milan, NeuroMi University of Milan Bicocca
Via Cadore n° 48, 20052 Monza (MB), Italy
E-mail: [email protected]
Received date: October 22, 2014; Accepted date: December 04, 2014; Published date: December 10, 2014
Citation: Francesco C, Annalisa P, Ambra G, Francesca C, Luca S et al. (2015) Genetic Risk Assessment of Periodontal Disease in Healthy Patients. J Forensic Res 6:260. doi: 10.4172/2157-7145.1000260
Copyright: © 2015 Francesco C et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Introduction: About 30% of the general population manifests periodontal disease (PD). Patients with parents with a compromised periodontal condition may need prosthetic or implantology treatment (PIT), therefore those patients are at increased risk of developing PD during or after dental treatment. Hence the use of a genetic test for identify those most at risk of PD and submit them to very closely oral hygiene protocols, is mandatory. PIT of these patients must be done safely having previously assessed the risk of developing PD. Polymorphisms of IL6 and IL10 constitute risk factors for chronic periodontitis, so the use of a genetic test is fundamental to ensure a correct preventive protocol and plaque control in healthy patients.